Your session is about to expire
← Back to Search
GOLO for Life® Plan + Release for Type 2 Diabetes and Obesity
Study Summary
This trial is studying the effect of a diet & supplement plan on weight & glycemic control for those with Type 2 Diabetes. Safety & tolerability of the plan will be measured.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am taking medications or supplements that could affect my blood sugar, weight, or metabolism.I haven't had major surgery in the last 3 months and don't plan any during the study.I have had surgery to help me lose weight.My kidneys and liver are currently stable, except I may have had kidney stones but have been symptom-free for 6 months.I have Type 1 diabetes.My cancer, except for fully treated skin cancer, has been in remission for over 5 years.I have had a gout flare-up within the last year.I am between 18 and 75 years old.I have type 2 diabetes and am being treated with insulin.I have a thyroid condition and have been on a stable medication dose for 3+ months.I agree to keep my lifestyle, medication, and sleep habits the same during the study.I have or had serious stomach or intestine problems.I am able to understand and agree to the study's procedures and risks.I am a woman who cannot become pregnant due to sterilization or being post-menopausal for over a year.I use cannabis more than once a month or will stop using it for the study.My HbA1c level is 6.0% or higher, and my diabetes medication hasn't changed in the last 3 months.I have not donated blood within 30 days before the study and will not during or within 30 days after.
- Group 1: GOLO for Life® Plan (G4LP) and Release Supplement
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the GOLO for Life® Plan (G4LP) and Release Supplement been granted regulatory approval by the FDA?
"We have assessed the safety of GOLO for Life® Plan (G4LP) and Release Supplement to be a 2 on a scale from 1-3. This is due to existing evidence that supports its security, although there are no studies confirming efficacy."
May I be eligible to participate in this research?
"In order to be eligible, participants must possess a BMI above the healthy range and fall between 18-65 years old. The maximum capacity for this trial is 100 applicants."
Are there any available opportunities for participants in this experiment?
"Affirmative. Clinicaltrials.gov's findings reveal that this research is actively seeking participants, which was posted on April 20th of 2021 and most recently updated on the 25th of the same month. The scope entails recruiting 100 patients from 2 different medical centres."
Is the eligibility for this trial confined to individuals aged 18 or above?
"This research study is looking for individuals that have reached the legal age of consent and are below 65 years old. For those under 18, there are 250 studies available while 1,304 trials cover seniors over 65 years of age."
How many participants are currently engaged in this clinical trial?
"Indeed, the information available on clinicaltrials.gov states that this research endeavour is actively seeking participants. It was initially posted on April 20th of 2021 and last edited four days later; it requires 100 individuals from two locations for completion."
Share this study with friends
Copy Link
Messenger